Apellis Pharmaceuticals Faces Increased Bearish Sentiment Amid Options Activity
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 01 2026
0mins
Source: Coinmarketcap
Apellis Pharmaceuticals Inc (APLS) experienced a significant price drop of 16.37% as it crossed below its 5-day SMA, reflecting heightened bearish sentiment among investors.
The surge in options volume, particularly the $25 strike put option expiring on January 16, 2026, which traded 7,553 contracts, indicates a strong expectation of further declines in APLS's stock price. This activity suggests that investors are increasingly betting against the stock, contributing to its downward movement.
The implications of this bearish sentiment could lead to increased volatility for APLS in the near term, as investors react to the heightened options activity and reassess their positions in light of market conditions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
